Clinical Trial Update: Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal irinotecan with fluorouracil and leucovorin in patients with refractory advanced high-grade neuroendocrine carcinoma of the g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neuroendocrine Carcinoma
• Pancreatic Neuroendocrine Carcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Locally Advanced Digestive System Neuroendocrine Carcinoma, Locally Advanced Pancreatic Neuroendocrine Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2023-12-19